A new study identifies how certain proteins in the immune system interact leading to organ rejection. The study, which involved experiments on mice and human patients, uncovered an important ...
CM24 combined with Opdivo and chemotherapy showed significant survival benefits in pancreatic cancer patients with CEACAM1 biomarkers. The study reported up to a 90% reduction in risk of death in ...